| scholarly article | Q13442814 |
| P50 | author | Michael Wakelam | Q15994807 |
| Edward A. Dennis | Q54261384 | ||
| Federico Torta | Q55098120 | ||
| Tze Ping Loh | Q56815970 | ||
| Craig E. Wheelock | Q57306353 | ||
| Kim Ekroos | Q58885412 | ||
| Peter J Meikle | Q59684533 | ||
| Bo Burla | Q61793973 | ||
| Makoto Arita | Q87827614 | ||
| Xianlin Han | Q88520691 | ||
| Andrej Shevchenko | Q89445183 | ||
| Oswald Quehenberger | Q90193728 | ||
| Anne K Bendt | Q90987702 | ||
| Markus R. Wenk | Q90987707 | ||
| Amaury Cazenave-Gassiot | Q38359522 | ||
| Matej Orešič | Q38591100 | ||
| Gerhard Liebisch | Q42705098 | ||
| P2093 | author name string | Kazutaka Ikeda | |
| Masanori Arita | |||
| Michelle K Lin | |||
| P2860 | cites work | Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma. | Q46544317 |
| Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. | Q46581833 | ||
| Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides | Q46588935 | ||
| Identification and Annotation of Lipid Species in Metabolomics Studies Need Improvement | Q46641461 | ||
| Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma. | Q46649890 | ||
| CLSI C62-A: A New Standard for Clinical Mass Spectrometry | Q46790495 | ||
| High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
| Long-Term Stability of Human Plasma Metabolites during Storage at -80 °C. | Q47731230 | ||
| Effect of storage time, temperature, antioxidant and thawing on fatty acid composition of plasma, serum and red blood cells - A pilot biobank study | Q47751816 | ||
| Long-term performance and stability of molecular shotgun lipidomic analysis of human plasma samples | Q47848884 | ||
| Simultaneous determination of tryptophan and 8 metabolites in human plasma by liquid chromatography/tandem mass spectrometry | Q47914356 | ||
| The effect of haemolysis on the metabolomic profile of umbilical cord blood | Q48320963 | ||
| Shotgun Lipidomics Approach for Clinical Samples. | Q49834377 | ||
| Fast and accurate quantitative organic acid analysis with LC-QTOF/MS facilitates screening of patients for inborn errors of metabolism. | Q50045493 | ||
| Multiplex quantitative analysis of eicosanoid mediators in human plasma and serum: Possible introduction into clinical testing. | Q50069407 | ||
| How can Omic Science be improved? | Q50124726 | ||
| Quantifying protein measurands by peptide measurements: where do errors arise? | Q50602673 | ||
| An improved reference measurement procedure for triglycerides and total glycerides in human serum by isotope dilution gas chromatography-mass spectrometry. | Q50723679 | ||
| Analytes related to erythrocyte metabolism are reliable biomarkers for preanalytical error due to delayed plasma processing in metabolomics studies. | Q50961171 | ||
| The effect of centrifugation speed and time on pre-analytical platelet activation. | Q51739898 | ||
| Liquid chromatography-tandem mass spectrometry-based plasma metabonomics delineate the effect of metabolites' stability on reliability of potential biomarkers. | Q51832775 | ||
| Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood. | Q52641925 | ||
| Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. | Q52881555 | ||
| Preanalytical standardization of sphingosine-1-phosphate, sphinganine-1-phosphate and sphingosine analysis in human plasma by liquid chromatography-tandem mass spectrometry. | Q54357055 | ||
| Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. | Q55408734 | ||
| Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry | Q56974325 | ||
| Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids | Q80476879 | ||
| Evaluating interference caused by lipemia | Q80901612 | ||
| Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies | Q83293616 | ||
| Time to face the fats: what can mass spectrometry reveal about the structure of lipids and their interactions with proteins? | Q84302511 | ||
| Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy | Q87111619 | ||
| Plasma Lipidomics of Healthy Japanese Adults Reveals Gender- and Age-Related Differences | Q88042926 | ||
| Lipidomic Analysis | Q88067071 | ||
| Potential and Caveats of Lipidomics for Cardiovascular Disease | Q88582805 | ||
| Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination | Q89454020 | ||
| A comprehensive classification system for lipids | Q22306239 | ||
| Characterization of cardiolipins and their oxidation products by LC-MS analysis | Q23924134 | ||
| Lipidomics reveals a remarkable diversity of lipids in human plasma | Q24633282 | ||
| Update of the LIPID MAPS comprehensive classification system for lipids | Q24652954 | ||
| LMSD: LIPID MAPS structure database | Q24675592 | ||
| A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION | Q25939000 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Data standards can boost metabolomics research, and if there is a will, there is a way | Q26776402 | ||
| The human plasma lipidome | Q26830940 | ||
| Platelet lipidomics: modern day perspective on lipid discovery and characterization in platelets | Q26998976 | ||
| MassBank: a public repository for sharing mass spectral data for life sciences | Q27809667 | ||
| MetaboLights--an open-access general-purpose repository for metabolomics studies and associated meta-data | Q27818909 | ||
| Biological Matrix Effects in Quantitative Tandem Mass Spectrometry-Based Analytical Methods: Advancing Biomonitoring | Q28082483 | ||
| Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age | Q28397688 | ||
| A Golden Age for Working with Public Proteomics Data | Q28519626 | ||
| An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids | Q28611371 | ||
| COordination of Standards in MetabOlomicS (COSMOS): facilitating integrated metabolomics data access | Q28611417 | ||
| mzML--a community standard for mass spectrometry data | Q28743778 | ||
| ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level | Q28749402 | ||
| The minimum information about a proteomics experiment (MIAPE) | Q29615391 | ||
| STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies | Q30278455 | ||
| Reporting of lipidomics data should be standardized | Q31166325 | ||
| Common cases of improper lipid annotation using high-resolution tandem mass spectrometry data and corresponding limitations in biological interpretation | Q31171207 | ||
| Haematocrit: within-subject and seasonal variation | Q33186517 | ||
| Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration | Q33405952 | ||
| Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue | Q33840123 | ||
| Differences between human plasma and serum metabolite profiles | Q33961437 | ||
| Blood sphingolipidomics in healthy humans: impact of sample collection methodology | Q34116310 | ||
| LipidXplorer: a software for consensual cross-platform lipidomics | Q34137373 | ||
| Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study | Q34640755 | ||
| Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis | Q34757421 | ||
| Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 | Q34803113 | ||
| A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language | Q34964438 | ||
| Metabolite profiling of a NIST Standard Reference Material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources | Q35023775 | ||
| Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids | Q35070934 | ||
| The Impact of Sample Storage Time on Estimates of Association in Biomarker Discovery Studies | Q35090470 | ||
| Biomarkers of NAFLD progression: a lipidomics approach to an epidemic | Q35120968 | ||
| Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance | Q35192897 | ||
| Heparin-enhanced plasma phospholipase A2 activity and prostacyclin synthesis in patients undergoing cardiac surgery | Q35552772 | ||
| Pre-analytical sample quality: metabolite ratios as an intrinsic marker for prolonged room temperature exposure of serum samples | Q35590383 | ||
| Effects of pre-analytical processes on blood samples used in metabolomics studies | Q35753268 | ||
| An Efficient Single Phase Method for the Extraction of Plasma Lipids. | Q35829914 | ||
| Novel advances in shotgun lipidomics for biology and medicine | Q35878177 | ||
| Fully automated semi-quantitative toxicological screening in three biological matrices using turbulent flow chromatography/high resolution mass spectrometry | Q35904960 | ||
| Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples | Q36118672 | ||
| Applications of mass spectrometry to lipids and membranes | Q36135725 | ||
| Standardization of total cholesterol measurement in population surveys--pre-analytic sources of variation and their effect on the prevalence of hypercholesterolaemia. | Q36155184 | ||
| The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. | Q36302559 | ||
| Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia | Q36307308 | ||
| Biomarkers of oxidative damage in human disease. | Q36399178 | ||
| Discovering and validating between-subject variations in plasma lipids in healthy subjects | Q36442689 | ||
| The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. | Q36520373 | ||
| Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics | Q36558343 | ||
| Development of a Standard Reference Material for metabolomics research | Q36771699 | ||
| LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic acid levels | Q36845243 | ||
| Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects | Q36984424 | ||
| Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome | Q37000534 | ||
| Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why? | Q37099149 | ||
| Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humans | Q37143607 | ||
| Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma | Q37155265 | ||
| Plasma lipid profiling in a large population-based cohort | Q37163090 | ||
| A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood | Q37187622 | ||
| Effects of sample handling and storage on quantitative lipid analysis in human serum | Q37478161 | ||
| Lipemia: causes, interference mechanisms, detection and management | Q37607322 | ||
| Interferences from blood collection tube components on clinical chemistry assays | Q37607345 | ||
| High throughput quantitative molecular lipidomics | Q37902290 | ||
| Esterified eicosanoids: generation, characterization and function | Q37971413 | ||
| Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders | Q38105751 | ||
| Lipidomics: quest for molecular lipid biomarkers in cardiovascular disease | Q38291460 | ||
| The Proteomics Standards Initiative: Fifteen Years of Progress and Future Work. | Q38371542 | ||
| Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus. | Q38386249 | ||
| Preanalytical variables affecting the integrity of human biospecimens in biobanking | Q38484066 | ||
| Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles | Q38683633 | ||
| Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences | Q38803730 | ||
| Lipidomics in biomedical research-practical considerations | Q38837670 | ||
| Pre-analytical phase management: a review of the procedures from patient preparation to laboratory analysis | Q39165311 | ||
| Does centrifugation matter? Centrifugal force and spinning time alter the plasma metabolome | Q39301219 | ||
| Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality | Q39547122 | ||
| Metabolomic Quality Assessment of EDTA Plasma and Serum Samples | Q39651753 | ||
| Thawing as a critical pre-analytical step in the lipidomic profiling of plasma samples: New standardized protocol | Q39964695 | ||
| Preanalytical Investigation of Polyunsaturated Fatty Acids and Eicosanoids in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry | Q39990939 | ||
| Shorthand notation for lipid structures derived from mass spectrometry. | Q40470345 | ||
| Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation | Q40531538 | ||
| Erythrocyte sedimentation rate and fibrinogen concentration of whole blood influences the cellular composition of platelet-rich plasma obtained from centrifugation methods | Q41672553 | ||
| Establishing multiple omics baselines for three Southeast Asian populations in the Singapore Integrative Omics Study. | Q41693691 | ||
| Quantitative assays for esterified oxylipins generated by immune cells | Q41890546 | ||
| HMDB 4.0: the human metabolome database for 2018. | Q43212324 | ||
| Erythrocyte mechanical fragility is increased in patients with type 2 diabetes | Q45132353 | ||
| Minimizing artifactual elevation of lipid peroxidation products (F2-isoprostanes) in plasma during collection and storage. | Q45928126 | ||
| Comprehensive analyses of oxidized phospholipids using a measured MS/MS spectra library | Q46311704 | ||
| Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans | Q46410966 | ||
| Preanalytical aspects and sample quality assessment in metabolomics studies of human blood | Q46542405 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood plasma | Q79749 |
| endocrinology | Q162606 | ||
| P1104 | number of pages | 17 | |
| P304 | page(s) | 2001-2017 | |
| P577 | publication date | 2018-08-16 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines | |
| P478 | volume | 59 |
| Q64290629 | A Polymer Coating Transfer Enrichment Method for Direct Mass Spectrometry Analysis of Lipids in Biofluid Samples |
| Q96431872 | A lipidome atlas in MS-DIAL 4 |
| Q93186219 | Comparison of Single Phase and Biphasic Extraction Protocols for Lipidomic Studies Using Human Plasma |
| Q111269205 | Comparison of lipidome profiles of Caenorhabditis elegans—results from an inter-laboratory ring trial |
| Q91811972 | Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health |
| Q89789390 | Hexacosenoyl-CoA is the most abundant very long-chain acyl-CoA in ATP binding cassette transporter D1-deficient cells |
| Q92511123 | Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence |
| Q91833431 | Lipidomics from sample preparation to data analysis: a primer |
| Q97643669 | Lipidomics needs more standardization |
| Q97412613 | Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening |
| Q89820039 | Plasma Lipidomic Analyses in Cohorts With mTBI and/or PTSD Reveal Lipids Differentially Associated With Diagnosis and APOE ε4 Carrier Status |
| Q92702462 | Quantification of Fecal Short Chain Fatty Acids by Liquid Chromatography Tandem Mass Spectrometry-Investigation of Pre-Analytic Stability |
| Q60954147 | Quantification of Lipids: Model, Reality, and Compromise |
| Q90547651 | Quantification of diacylglycerol and triacylglycerol species in human fecal samples by flow injection Fourier transform mass spectrometry |
| Q92811269 | Quantitative Fragmentation Model for Bottom-Up Shotgun Lipidomics |
| Q91660449 | Serum lipidome analysis of healthy beagle dogs receiving different diets |
| Q90010373 | Sphingolipids as Biomarkers of Disease |
| Q58117049 | Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia |
| Q93109127 | Tissue-Specific Sample Dilution: An Important Parameter to Optimise Prior to Untargeted LC-MS Metabolomics |
| Q93167993 | Tools and resources for metabolomics research community: A 2017-2018 update |
| Q89511039 | Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine |
| Q92711533 | Trapped ion mobility spectrometry and PASEF enable in-depth lipidomics from minimal sample amounts |
| Q92753621 | Ultra-High Mass Resolving Power, Mass Accuracy, and Dynamic Range MALDI Mass Spectrometry Imaging by 21-T FT-ICR MS |
Search more.